VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $3,641,000 | -72.2% | 35,822 | -51.1% | 1.69% | -72.8% |
| Q3 2015 | $13,078,000 | +63.2% | 73,316 | +103.2% | 6.21% | +123.2% |
| Q2 2015 | $8,014,000 | +3.3% | 36,073 | -7.7% | 2.78% | +9.6% |
| Q1 2015 | $7,761,000 | +79.0% | 39,076 | +13.7% | 2.54% | +69.1% |
| Q2 2014 | $4,336,000 | -59.7% | 34,382 | -57.8% | 1.50% | -69.0% |
| Q1 2014 | $10,751,000 | -28.5% | 81,550 | -36.3% | 4.85% | -31.8% |
| Q4 2013 | $15,038,000 | +33.6% | 128,088 | +18.7% | 7.11% | +18.1% |
| Q3 2013 | $11,259,000 | +33.8% | 107,917 | +10.4% | 6.02% | +17.9% |
| Q2 2013 | $8,413,000 | – | 97,737 | – | 5.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |